Ascendis Health Limited (ASC.JO)
ZAc 78.0
(0.0%)
ZAc 78.0
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 396.89 Million ZAR | 8.46% |
| 2022 | 365.93 Million ZAR | -1.59% |
| 2021 | 371.86 Million ZAR | -18.1% |
| 2020 | 454.04 Million ZAR | -71.31% |
| 2019 | 1.58 Billion ZAR | 42.69% |
| 2018 | 1.1 Billion ZAR | -31.51% |
| 2017 | 1.61 Billion ZAR | 1.36% |
| 2016 | 1.59 Billion ZAR | 70.0% |
| 2015 | 939.82 Million ZAR | 60.63% |
| 2014 | 585.08 Million ZAR | 35.59% |
| 2013 | 431.51 Million ZAR | 154.59% |
| 2012 | 169.49 Million ZAR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q1 | 401.51 Million ZAR | 9.72% |
| 2023 FY | 396.89 Million ZAR | 8.46% |
| 2023 Q4 | 396.89 Million ZAR | 0.0% |
| 2023 Q3 | 396.89 Million ZAR | -1.15% |
| 2023 Q2 | 401.51 Million ZAR | 0.0% |
| 2022 Q4 | 365.93 Million ZAR | 0.0% |
| 2022 Q2 | 439.53 Million ZAR | 0.0% |
| 2022 Q3 | 365.93 Million ZAR | -16.74% |
| 2022 FY | 365.93 Million ZAR | -1.59% |
| 2022 Q1 | 439.53 Million ZAR | 18.2% |
| 2021 Q1 | 151.44 Million ZAR | -66.65% |
| 2021 Q2 | 151.44 Million ZAR | 0.0% |
| 2021 Q3 | 371.86 Million ZAR | 145.55% |
| 2021 Q4 | 371.86 Million ZAR | 0.0% |
| 2021 FY | 371.86 Million ZAR | -18.1% |
| 2020 Q4 | 454.04 Million ZAR | 0.0% |
| 2020 FY | 454.04 Million ZAR | -71.31% |
| 2020 Q1 | 1.34 Billion ZAR | -14.75% |
| 2020 Q2 | 1.34 Billion ZAR | 0.0% |
| 2020 Q3 | 454.04 Million ZAR | -66.35% |
| 2019 FY | 1.58 Billion ZAR | 42.69% |
| 2019 Q1 | 1.59 Billion ZAR | 44.17% |
| 2019 Q2 | 1.59 Billion ZAR | 0.0% |
| 2019 Q3 | 1.58 Billion ZAR | -1.03% |
| 2019 Q4 | 1.58 Billion ZAR | 0.0% |
| 2018 Q1 | 1.85 Billion ZAR | 14.69% |
| 2018 Q4 | 1.1 Billion ZAR | -27.65% |
| 2018 Q3 | 1.53 Billion ZAR | -17.46% |
| 2018 Q2 | 1.85 Billion ZAR | 0.0% |
| 2018 FY | 1.1 Billion ZAR | -31.51% |
| 2017 Q4 | 1.61 Billion ZAR | 2.89% |
| 2017 Q2 | 1.75 Billion ZAR | 0.0% |
| 2017 Q1 | 1.75 Billion ZAR | 9.63% |
| 2017 FY | 1.61 Billion ZAR | 1.36% |
| 2017 Q3 | 1.57 Billion ZAR | -10.14% |
| 2016 FY | 1.59 Billion ZAR | 70.0% |
| 2016 Q2 | 1.4 Billion ZAR | 0.0% |
| 2016 Q3 | 1.59 Billion ZAR | 13.49% |
| 2016 Q4 | 1.59 Billion ZAR | 0.0% |
| 2016 Q1 | 1.4 Billion ZAR | 49.79% |
| 2015 FY | 939.82 Million ZAR | 60.63% |
| 2015 Q1 | 762.21 Million ZAR | 30.28% |
| 2015 Q4 | 939.82 Million ZAR | 0.05% |
| 2015 Q3 | 939.35 Million ZAR | 23.24% |
| 2015 Q2 | 762.21 Million ZAR | 0.0% |
| 2014 Q2 | 520.32 Million ZAR | 0.0% |
| 2014 FY | 585.08 Million ZAR | 35.59% |
| 2014 Q1 | 520.32 Million ZAR | 20.58% |
| 2014 Q3 | 582.09 Million ZAR | 11.87% |
| 2014 Q4 | 585.08 Million ZAR | 0.51% |
| 2013 Q2 | 344.54 Million ZAR | 0.0% |
| 2013 Q3 | 414.23 Million ZAR | 20.23% |
| 2013 Q4 | 431.51 Million ZAR | 4.17% |
| 2013 FY | 431.51 Million ZAR | 154.59% |
| 2013 Q1 | 344.54 Million ZAR | 103.28% |
| 2012 Q4 | 169.49 Million ZAR | 0.0% |
| 2012 FY | 169.49 Million ZAR | 0.0% |
| 2012 Q1 | - ZAR | 0.0% |
| 2012 Q3 | 169.49 Million ZAR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|